In the News

Earth Science Tech, Inc. (ETST) Introduces New Chief Operations Officer, (COO), Achieving Q1 Goal

DORAL, FL – March 20, 2018 via (GLOBE NEWSWIRE) – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces new COO, Gagan Hunter, Achieving Q1 Goal of February.


The Company’s current President, Director, and COO, Nickolas Tabraue, alleviates his role as COO to Gagan. Mr. Hunter will use his excessive experience and skill sets to maintain the Company operations in order and efficient while expanding and progressing. While Mr. Tabraue continues his roles as President and Director to concentrate implementing the Company’s growth strategy and further build the Company.


A graduate of Oaksterdam University, America’s first primer cannabis college, University of Pittsburgh, and post graduate studies at the Temple University, Gagan Hunter is a holistic health specialist, cannabis & cannabinoid (CBD) educator. Mr. Hunter has 20 years of natural products industry experience in sales, marketing, and management, and 20 years teaching nutrition. His skills obtained through his 20 years in the industry are staff training, purchasing, customer service, inventory control, and financial management.


The new COO, shares his first statement with, “ I’m truly excited to be part of the Earth Science Tech, Inc. team, I have known and worked with Jill Buzan for over 17 years and Gabe for 5 years. Being part of the Company truly makes me feel at home and part of the family. I look forward on strengthening the Company’s operations and making sure the efficiency stay consistent as the growth continues.”


Nickolas Tabraue, ends with, “I feel that we finally have the last piece of our puzzle in place to take ETST to new heights. Gagan has many great ideas to implement that’ll help the Company work more efficiently and organized. We now have every major role managed by passionate like minded individuals to truly make ETST the innovative trusted brand in the alternative medicine space. I plan on sharing updates on our audit, Tier II Reg A+, up-listing, and other working matters as soon as they progress.”


About Earth Science Tech, Inc. (ETST)

Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit:

About Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit:

About Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit:

About KannaBidioiD

KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit:

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:

Dave Demarest

305.546.7640 Office


Company Contact:

Nickolas S. Tabraue

President, Director, Chief Operating Officer

305.615.2118 Office

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office